But there are a few key differences. Most importantly, Moderna’s vaccine can be stored in normal freezers and does not require a super-cold transportation network, making it more accessible for smaller facilities and local communities.
The US Food and Drug Administration has granted emergency use authorization to Moderna for its vaccine, and the US Centers for Disease Control and Prevention has recommended the vaccine for people ages 18 and older.Here’s a look at what we know about the Moderna vaccine and how it compares to Pfizer’s.
What is Moderna?
Moderna headquarters in Cambridge, Massachusetts.While Pfizer is a pharmaceutical behemoth, Moderna — short for modified RNA — is a biotech company based in Cambridge, Massachusetts.
Established in 2010, Moderna has never brought a product to market, or gotten any of its nine or so vaccine candidates approved for use by the FDA. It had also never brought a product to phase three of a clinical trial previously.
The company’s scientists had already been collaborating with researchers from the National Institutes of Health on a vaccine for another coronavirus, Middle Eastern Respiratory Syndrome (MERS). When Chinese researchers released the genomic sequence for the novel coronavirus in mid-January, they had a jump start.
The vaccine, called mRNA-1273, had development help from the National Institute of Allergy and Infectious Diseases. The US Biomedical Advance Research and Development Authority, known as BARDA, supported late-stage clinical trials and has helped scale up manufacturing.
The FDA green-lit clinical trials of Moderna’s vaccine on March 3, the first out of the gate. Its advanced stage clinical trial started July 27 and it was the first government-funded Phase 3 clinical trial for a Covid-19 vaccine in the US. The company applied to the FDA for emergency use authorization for the vaccine on November 30.
Does the vaccine work?
The Moderna vaccine was effective in preventing Covid-19 cases in total and in limiting severe Covid-19 during the trial.
The vaccine’s efficacy against Covid-19 was 94.1%, occurring at least 14 days after the second dose, according to a briefing document released by an advisory committee to the FDA.
more recommended stories
Yucatan registers over 60 infections by Covid in 24 hours
On May 19th, the administration of.
“Live without Drugs” campaign connects with Yucatecan students
The Segey and Fundación Azteca convene.
On Thursday, May 19th, the Mérida Airport registered a total of 54 flights, all on schedule
On Thursday, May 19th, three flights.
Mérida joins the national mourning day for victims of femicide in Mexico
On Wednesday, May 18th at 6:00.
Vila Dosal promotes investments in clean energy for Yucatan
During the last day of his.
Driving under the influence, the mayor of Kinchil is involved in a traffic accident
In an embarrassing situation, the mayor.
3-year-old boy dies at La Raza IMSS hospital in Mexico City apparently due to a suspected case of acute hepatitis
The Hidalgo Health Secretariat confirmed that.
Police arrested two subjects in possession of large quantities of different drugs in Tulum, Quintana Roo
Security forces of the three levels.
Campeche Ministry of Health welcomes Cuban doctors brought by the AMLO administration
Campeche would be benefited from the.
Mauricio Vila signs an agreement with the Confederation of Cataluña
The Governor of Yucatan, Mauricio Vila.